Roberto Magalhães Pinto

Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects

Luís Almeida, José Rocha, Amílcar Falcão et al. · Clinical Pharmacokinetics · 2012 · 86 citations

Healthy Subjects, Novel Catechol-o-methyltransferase Inhibitor, Active Ingredient +4

Opicapone: a short lived and very long acting novel catechol‐<scp>O</scp>‐methyltransferase inhibitor following multiple dose administration in healthy subjects

José Rocha, Luís Almeida, Amílcar Falcão et al. · British Journal of Clinical Pharmacology · 2013 · 85 citations · Full text

Schistosoma mansoni: Vaccination with adult worm antigens

Mı́riam Tendler, Roberto Magalhães Pinto, A. Oliveira Lima et al. · International Journal for Parasitology · 1986 · 73 citations

Vaccination, Schistosoma Mansoni, Parasitic Disease +4

Patterns of infection with the nematodes Syphacia obvelata and Aspiculuris tetraptera in conventionally maintained laboratory mice

Telma Bazzano, Tamy Ingrid Restel, Roberto Magalhães Pinto et al. · Memórias do Instituto Oswaldo Cruz · 2002 · 66 citations · Full text

Parasitic Disease, Entomology, Immunology +17

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

José‐Francisco Rocha, Amílcar Falcão, A. Santos et al. · European Journal of Clinical Pharmacology · 2014 · 65 citations

Levodopa Pharmacokinetics, Pharmacology, Neuropharmacology +3